No institution can boast a more solid foundation than that on which Freemasonry rests - the practice of every moral and social virtue!
The Masonic Samaritan Fund
Which medical research study did your region vote to support?
To mark the 25th anniversary of the MSF, the Fund invited Freemasons from across England and Wales to nominate one proposal from an agreed shortlist of research projects based in, or near their region.
The chosen medical research projects will each receive a share of the MSF Silver Jubilee Research Fund. Here are the results from your region.
As you can see the vote was very close and the difference in support for research into cancer and diabetes was only 2%. Therefore, the MSF Trustees have decided to allocate a further £129,000 to the Silver Jubilee Research Fund and provide grants to both research Charities.
This means that the MSF will award two research grants in your region totalling £144,000. This is how it breaks down:
Tenovus Cancer Care | £89,000 - Diabetes UK | £55,000 - Total: £144,000
You can read more about the research projects in MSF's online booklet and over the coming months, the Fund will organise local cheque presentations which they will strive to get published in local papers.
Thanks to your votes, the people suffering from cancer and diabetes can benefit from the generous donations the MSF receive from the Masonic community. We look forward to keeping you up to date on the progress of the chosen research projects once they get under way.
Breakthrough in Alzheimer's research thanks to £181K grant by the Masonic Samaritan Fund
Research funded by the Masonic Samaritan Fund has successfully developed a blood test that could predict whether someone with early memory problems will develop Alzheimerís within a year. The MSF awarded £181,723 to Alzheimerís Research UK in 2011 to fully fund the first two years of Professor Lovestoneís research.
This is a significant breakthrough in dementia research as it enables scientists to test potential new treatments on people with the earliest stages of Alzheimerís disease.
Previously, by the time people received a diagnosis and were able to take part in clinical trials their dementia had progressed beyond the point where useful insights into the treatmentís effectiveness could be captured. The blood test will help researchers target groups of people for future studies, driving the search for new treatments forward and bringing us closer to a cure faster.
Listen to Prof Lovestone, the renowned study leader, talk more about his pioneering research on this podcast.
We hope you have found this news as exciting as we have. We look forward to sharing future updates with you.
Grants Director and Deputy Chief Executive.
Freemasonry benefits both the Local & National Community
Freemasons make a major contribution to society through their own charities, as well as through donations to UK charities and worldwide disaster relief funds, with members playing an active role in their communities.
The Masonic Fishing Charity | Teddies for Loving Care | Freemasons Grand Charity | Masonic Benevolent Association